99 related articles for article (PubMed ID: 7092575)
1. Effect of probucol on bile composition in man.
Jirsa M; Marecek Z; Kerdac V; Kucerova L
Artery; 1982; 10(1):44-7. PubMed ID: 7092575
[No Abstract] [Full Text] [Related]
2. [The effect of probucol of bile composition].
Marecek Z; Jirsa M; Kordac V; Kucerová K
Vnitr Lek; 1981 Jul; 27(7):667-70. PubMed ID: 7303501
[No Abstract] [Full Text] [Related]
3. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)].
Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V
Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
Leijd B
Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
[No Abstract] [Full Text] [Related]
5. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
Beaumont V
Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
[No Abstract] [Full Text] [Related]
6. Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis.
Nestel PJ; Billington T
Atherosclerosis; 1981; 38(1-2):203-9. PubMed ID: 7470200
[TBL] [Abstract][Full Text] [Related]
7. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
Artery; 1982; 10(1):71-87. PubMed ID: 7092577
[TBL] [Abstract][Full Text] [Related]
8. Probucol-lipid pharmacology.
Kritchevsky D
Artery; 1982; 10(1):1-6. PubMed ID: 6807261
[No Abstract] [Full Text] [Related]
9. [The effects of probucol in man (author's transl)].
Leutenegger M
Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
[TBL] [Abstract][Full Text] [Related]
10. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)].
Mc Caughan D
Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444
[TBL] [Abstract][Full Text] [Related]
11. [Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
Sznajderman M; Zawadzki Z
Kardiol Pol; 1985; 28(10):628-36. PubMed ID: 3938501
[No Abstract] [Full Text] [Related]
12. [Experimental pharmacology of probucol (author's transl)].
Choisy H; Millart H
Nouv Presse Med; 1980 Oct; 9(40):2981-4. PubMed ID: 7443435
[TBL] [Abstract][Full Text] [Related]
13. Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia.
Dachet C; Motta C; Neufcour D; Jacotot B
Adv Exp Med Biol; 1988; 243():179-84. PubMed ID: 3223415
[No Abstract] [Full Text] [Related]
14. Effects of probucol on lipoprotein protein kinetics.
Nestel PJ
Artery; 1982; 10(2):95-8. PubMed ID: 7092582
[TBL] [Abstract][Full Text] [Related]
15. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
[No Abstract] [Full Text] [Related]
16. [Probucol: mechanism of action (author's transl)].
Infante R
Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
[TBL] [Abstract][Full Text] [Related]
17. Influence of probucol on cholesterol and lipoprotein metabolism in man.
Kesäniemi YA; Grundy SM
J Lipid Res; 1984 Aug; 25(8):780-90. PubMed ID: 6491523
[TBL] [Abstract][Full Text] [Related]
18. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
[TBL] [Abstract][Full Text] [Related]
19. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
[No Abstract] [Full Text] [Related]
20. Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.
Tanno N; Oikawa S; Koizumi M; Kotake H; Hirakawa H; Kanazawa Y; Toyota T
Dig Dis Sci; 1994 Jul; 39(7):1586-91. PubMed ID: 8026274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
